222 related articles for article (PubMed ID: 18661642)
1. FDA notifications. Revised atazanavir package insert.
AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
[No Abstract] [Full Text] [Related]
2. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
Huff B
GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
[No Abstract] [Full Text] [Related]
3. New protease inhibitor atazanavir (Reyataz) approved.
AIDS Treat News; 2003 Jun; (392):3. PubMed ID: 12913956
[No Abstract] [Full Text] [Related]
4. FDA notifications. Reyataz is approved for HIV treatment.
AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
[TBL] [Abstract][Full Text] [Related]
5. FDA notifications. BMS issues letter about omeprazole.
AIDS Alert; 2005 Apr; 20(4):45-6. PubMed ID: 15841529
[No Abstract] [Full Text] [Related]
6. Atazanavir background documents available.
AIDS Treat News; 2003 May; (391):3. PubMed ID: 12866495
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions. Atazanavir and acid-reducing agents.
TreatmentUpdate; 2006; 18(3):4. PubMed ID: 17209238
[No Abstract] [Full Text] [Related]
8. Indinavir approved for HIV infection.
Am Fam Physician; 1996 May; 53(6):2203. PubMed ID: 8623727
[No Abstract] [Full Text] [Related]
9. New Norvir soft-gel capsule formulation approved by FDA.
Gaylord G
Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
[No Abstract] [Full Text] [Related]
10. Atazanavir gets FDA Advisory Committee's thumbs-up.
IAPAC Mon; 2003 Jun; 9(6):120. PubMed ID: 12951939
[No Abstract] [Full Text] [Related]
11. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
Schouten JT
STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
[TBL] [Abstract][Full Text] [Related]
12. HIV therapeutics, continued: another HIV protease inhibitor approved.
Laurence J
AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
[No Abstract] [Full Text] [Related]
13. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
[No Abstract] [Full Text] [Related]
14. FDA notifications. FDA approves new Kaletra formulation.
AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
[No Abstract] [Full Text] [Related]
15. 3TC and protease inhibitors: citizen's petition asks faster approval.
AIDS Treat News; 1995 Apr; (no 220):5. PubMed ID: 11362321
[TBL] [Abstract][Full Text] [Related]
16. Atazanavir (Reyataz).
Proj Inf Perspect; 2003 Oct; (36):7-10. PubMed ID: 14696568
[TBL] [Abstract][Full Text] [Related]
17. [New data on atazanavir/r]].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887
[No Abstract] [Full Text] [Related]
18. FDA approves SQV/r.
IAPAC Mon; 2004 Jan; 10(1):39. PubMed ID: 15108675
[No Abstract] [Full Text] [Related]
19. FDA notifications. Accelerated approval of tipranavir.
AIDS Alert; 2005 Nov; 20(11):131. PubMed ID: 16363051
[No Abstract] [Full Text] [Related]
20. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
